EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TSLP and TSLPR Expression Levels in Peripheral Blood as Potential Biomarkers in Patients with Chronic Rhinosinusitis with Nasal Polyps

Emma Moreno-Jiménez iD, Natalia Morgado, Manuel Gómez-García, Catalina Sanz iD, María Gil-Melcón, María Isidoro-García, Ignacio Dávila iD, Asunción García-Sánchez iD

International Journal of Molecular Sciences · 30.01.2025 · 26 (3) · 1227

DOI: 10.3390/ijms26031227 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.01.2025. Verfasst von Emma Moreno-Jiménez und 7 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Investigación Biomédica de Salamanca, 37007 Salamanca, Spain. Hauptthemen laut MEDLINE: Nasal Polyps, Sinusitis, Cytokines, Rhinitis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union, Instituto de Salud Carlos III (ISCIII) and European Union -NextGeneration EU, Mecanismo para la Recuperación y la Resiliencia (MRR), Instituto de Salud Carlos III (ISCIII) and European Regional Development Fund "A way to make Europe;.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TSLP is an alarmin released upon activation of epithelia in response to various external stimuli and is involved in type 2 cytokine-mediated pathological disorders. The formation of a high-affinity heterodimeric receptor complex, comprising the thymic stromal lymphopoietin receptor (TSLPR) chain and IL-7Rα, is required for signaling. This study investigated whether TSLP and TSLPR expression in peripheral blood or nasal polyps could provide a valuable approach for the molecular phenotyping of patients with chronic rhinosinusitis with nasal polyps (CRSwNP). The study population comprised 156 unrelated Caucasian individuals, including 45 controls and 111 patients with CRSwNP. Quantitative PCR analysis of TSLP and TSLPR was performed on the population study’s peripheral blood and nasal biopsy. The data were analyzed for potential associations, and possible use as a biomarker was studied. Significant differences were observed in TSLP and TSLPR blood expression between the control group and patients. Similarly, the expression of TSLP observed in biopsy samples was statistically significantly elevated in the polyp tissue of the patient compared with healthy controls. The combination of TSLP and TSLPR expression testing with peripheral blood eosinophils represents a more specific biomarker in patients exhibiting low eosinophil values. Further investigation of TSLP/TSLPR mRNA levels in peripheral blood may yield new minimally invasive biomarkers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nasal PolypsSinusitisCytokinesRhinitisReceptors, CytokineHumansFemaleBiomarkersMaleAdultMiddle AgedChronic DiseaseThymic Stromal LymphopoietinEosinophilsCase-Control StudiesAgedRhinosinusitis

Stichwörter der Autor:innen

CRSwNPN-ERDTSLPTSLPRbiomarkergene expressionnasal polyp

Substanzen

BiomarkersCytokinesReceptors, CytokineThymic Stromal LymphopoietinTSLP protein, humanCRLF2 protein, human

Autor:innen und Institutionen

  • Instituto de Investigación Biomédica de Salamanca, 37007 Salamanca, Spain.
  • Microbiology and Genetics Department, Universidad de Salamanca, 37007 Salamanca, Spain.
  • Clinical Biochemistry Department, Hospital Universitario de Salamanca, 37007 Salamanca, Spain.
  • Instituto de Salud Carlos III, Red de Enfermedades Inflamatorias-RICORS, 28029 Madrid, Spain.
  • Otorhinolaryngology and Head and Neck Surgery Department, Hospital Universitario de Salamanca, 37007 Salamanca, Spain.
  • Medicine Department, Universidad de Salamanca, 37007 Salamanca, Spain.

ORCID-Profile: Emma Moreno-Jiménez, Catalina Sanz, Ignacio Dávila, Asunción García-Sánchez

Förderung

  • Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union
  • Instituto de Salud Carlos III (ISCIII) and European Union -NextGeneration EU, Mecanismo para la Recuperación y la Resiliencia (MRR)
  • Instituto de Salud Carlos III (ISCIII) and European Regional Development Fund "A way to make Europe;
  • MCIN/AEI/10.13039/501100011033
  • Junta de Castilla y León
  • Sara Borrell postdoctoral fellowship from the ISCIII, co-funded by the European Social Fund
  • predoctoral grant PFIS, funded by ISCIII through the project "FI-21/00048" and co-funded by the EU.
  • predoctoral fellowship from the "Junta de Castilla y León" co-financing by the Ministry of Edu-cation, the European Social Fund Plus (FSE+) and the University…

Zitieren

APA

Moreno-Jiménez, E., Morgado, N., Gómez-García, M., Sanz, C., Gil-Melcón, M., Isidoro-García, M., Dávila, I., & García-Sánchez, A. (2025). TSLP and TSLPR Expression Levels in Peripheral Blood as Potential Biomarkers in Patients with Chronic Rhinosinusitis with Nasal Polyps. International Journal of Molecular Sciences, 26(3), 1227. https://doi.org/10.3390/ijms26031227

Vancouver

Moreno-Jiménez E, Morgado N, Gómez-García M, Sanz C, Gil-Melcón M, Isidoro-García M, et al. TSLP and TSLPR Expression Levels in Peripheral Blood as Potential Biomarkers in Patients with Chronic Rhinosinusitis with Nasal Polyps. International Journal of Molecular Sciences. 2025;26(3):1227. doi:10.3390/ijms26031227

BibTeX
@article{MorenoJimnez2025,
  author = {Moreno-Jiménez, Emma and Morgado, Natalia and Gómez-García, Manuel and Sanz, Catalina and Gil-Melcón, María and Isidoro-García, María and Dávila, Ignacio and García-Sánchez, Asunción},
  title = {TSLP and TSLPR Expression Levels in Peripheral Blood as Potential Biomarkers in Patients with Chronic Rhinosinusitis with Nasal Polyps},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {3},
  pages = {1227},
  doi = {10.3390/ijms26031227}
}
Kostenlos starten →